Plex Pharmaceuticals

About:

Plex Pharmaceuticals a biotechnology company aiming at treating ALS,

Top Investors: National Institute of Allergy and Infectious Diseases, National Institutes of Health

Description:

Plex's mission is to accelerate seminal academic discoveries into safe and effective treatments for unmet and under-served medical needs with a focus on neurodegenerative disorders.

Total Funding Amount:

$2.87M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2009-01-01

Contact Email:

bd(AT)plexpharma.com

Founders:

G. Sridhar Prasad

Number of Employees:

1-10

Last Funding Date:

2020-07-08

IPO Status:

Private

Industries: